Resistant hypertension is a serious form of high blood pressure that persists despite the use of at least three antihypertensive medications from different classes, including a diuretic. In a recent ...

Findings showed treatment with lorundrostat resulted in statistically significant reductions in systolic blood pressure compared with placebo. Topline data were announced from a phase 3 trial ...

Baxdrostat demonstrated a statistically significant and clinically meaningful reduction of systolic blood pressure compared with placebo WILMINGTON, Del.--(BUSINESS WIRE)-- Positive high-level results ...

A new guideline to diagnose and treat hypertension is aimed at helping primary care clinicians, including family physicians, nurses, nurse practitioners, and pharmacists, manage the disease. The new ...